Trial intelligence / Profile preview

Dexmedetomidine versus melatonin for postoperative delirium after coronary artery bypass graft surgery

IRCT20120214009011N3Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
May 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in delirium comparing Melatonin arm with Dexmedetomidine arm (2 arms). Primary endpoint: Delirium. Started May 2024; status: completed.

02

Drugs

dexmedetomidinemelatonin
03

Conditions

delirium

Beyond the preview

Go deeper on IRCT20120214009011N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120214009011N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call